|
"yang youngsen"的相关文件
显示项目 1-7 / 7 (共1页)
1
每页显示[10|25|50]项目
| 臺大學術典藏 |
2022-04-15T02:29:49Z |
Afatinib alone and in combination with vinorelbine or paclitaxel, in patients with HER2-positive breast cancer who failed or progressed on prior trastuzumab and/or lapatinib (LUX-Breast 2): an open-label, multicenter, phase II trial
|
Hickish, Tamas; Mehta, Ajay; Liu, Mei-Ching; CHIUN-SHENG HUANG; Arora, Rajendra Singh; Chang, Yuan-Ching; Yang, Youngsen; Vladimirov, Vladimir; Jain, Minish; Tsang, Janice; Pemberton, Karine; Sadrolhefazi, Behbood; Jin, Xidong; Tseng, Ling-Ming |
| 臺大學術典藏 |
2021-06-04T05:10:19Z |
Trastuzumab emtansine (T-DM1) versus trastuzumab in Chinese patients with residual invasive disease after neoadjuvant chemotherapy and HER2-targeted therapy for HER2-positive breast cancer in the phase 3 KATHERINE study
|
CHIUN-SHENG HUANG; Yang, Youngsen; Kwong, Ava; Chen, Shin-Cheh; Tseng, Ling-Ming; Liu, Mei-Ching; Shen, Kunwei; Wang, Shusen; Ng, Ting-Ying; Feng, Yi; Sun, Guofang; Yan, Iris Renfei; Shao, Zhimin |
| 臺大學術典藏 |
2021-03-03T10:26:44Z |
A phase ib study of alpelisib or buparlisib combined with tamoxifen plus goserelin in premenopausal women with HR-positive HER2-negative advanced breast cancer
|
Yen-Shen Lu; Lee, Keun Seok; Chao, Tsu Yi; Tseng, Ling Ming; Chitapanarux, Imjai; Chen, Shin Cheh; Liu, Chien Ting; Sohn, Joohyuk; Kim, Jee Hyun; Chang, Yuan Ching; Yang, Youngsen; Shotelersuk, Kanjana; Jung, Kyung Hae; Valenti, Roberta; Slader, Cassandra; Gao, Melissa; Park, Yeon Hee |
| 中山醫學大學 |
2018-01 |
Clinical features and outcome of lymphoma patients with pre-existing autoimmune diseases
|
Shih, Yu-Hsuan;Yang, Youngsen;Chang, Kuang-Hsi;Chen, Yi-Hsing;Teng, Chieh-Lin Jerry |
| 國立成功大學 |
2016-02-01 |
Results of Phase II trial of AUY922, a novel heat shock protein inhibitor in patients with metastatic gastrointestinal stromal tumor (GIST) and imatinib and sunitinib therapy.
|
Chiang, Nai-Jung;Yeh, Kun-Huei;Chiu, Chang-Fang;Chen, Jen-Shi;Yen, Chueh-Chuan;Lee, Kuan-Der;Lin, Yu-Lin;Bai, Li-Yuan;Chen, Ming-Huang;Lin, Jen-Shi;Yang, Youngsen;Rau, Kun-Ming;Hsiao, Hui-Hua;Shan, Yan-Shen;Chen, Li-Tzong |
| 國立成功大學 |
2014-12-06 |
No Differences in Outcomes Between Patients Achieving Early Molecular Response at 3 Months and Those Achieving Optimal Response at 6 or 12 Months in Chronic Phase of Chronic Myeloid Leukemia Treated with Front-Line Imatinib: Taiwan CML Study
|
Kuo, Ming-Chung; Chen, Tsai-Yun; Wang, Ming-Chung; Yang, Youngsen; Yeh, Su-Peng; Chang, Cheng-Shyong; Lan, Yii-Jenq; Chen, Chih-Cheng; Su, Yu-Chieh; Hsiao, Pei-Ching; Kuo, Ching-Yuan; Bai, Li-Yuan; Hwang, Wen-Li; Shih, Lee-Yung |
| 國立成功大學 |
2013-01 |
Emerging kinetics of BCR-ABL1 mutations and their effect on disease outcomes in chronic myeloid leukemia patients with imatinib failure
|
Shih, Lee-Yung; Kuo, Ming-Chung; Kuo, Ching-Yuan; Lin, Tseng-Hsi; Bai, Li-Yaun; Chen, Tsai-Yun; Wang, Ming-Chung; Lin, Tung-Liang; Lan, Yii-Jenq; Chen, Chih-Cheng; Yang, Youngsen; Hsiao, Pei-Ching; Lai, Chang-Liang; Chang, Chia-Hui; Lin, Tung-Huei |
显示项目 1-7 / 7 (共1页)
1
每页显示[10|25|50]项目
|
